期刊文献+

参附对大鼠失血性休克炎症因子的抑制作用 被引量:11

参附对大鼠失血性休克炎症因子的抑制作用
暂未订购
导出
摘要 目的探讨参附对大鼠失血性休克后早期炎症反应的抑制作用。方法将30只Wistar大鼠随机分为3组,每组10只,分别为空白对照组(A组)、失血休克模型组(B组)和参附治疗组(C组)。采用ELISA测定血清中IL-1β、IL-6、IL-10和TNF-α的浓度。结果 B组和C组血清IL-1β、IL-6、IL-10和TNF-a明显高于A组(P<0.01);B组和C组大鼠相比较,血清IL-1β、IL-6和TNF-α的含量增加,IL-10的含量降低,差异均有统计学意义(P<0.01)。结论参附可有效降低失血性休克后炎症因子的产生。 Objective To investigate the Shenfu inhibition of early inflammatory response after hemorrhagic shock in rats. Methods 30 Wistar rats were randomLy divided into three groups(n=10), the control group (A), hemorrhagic shock model group (B) and Shenfu treatment group (C group). The concentration of IL-1 β, IL-6, IL-10 and TNF- α was tested by ELISA. Results The serum IL-1β, IL-6, IL-10 and TNF-α of group B and group C was significantly higher than that in group A (P〈0.01); Compared to group B and group C, serum IL-1 β, IL-6 and TNF-α content increased and IL-10 content decreased, the differences were statistically significant (P〈0.01). Conclusion Shenfu can effectively reduce the production of inflammatory cytokines after hemorrhagic shock.
作者 白鹏举 武华
出处 《当代医学》 2013年第12期28-29,共2页 Contemporary Medicine
关键词 休克 出血性 炎症因子 参附 Shock Hemorrhagic Inflammatory factor Shenfu
  • 相关文献

参考文献10

  • 1Cocchi MN,KimLin E,Walsh M,et al.ldentification and resuscitation of the trauma patient in shock[J].Emerg Med Clin North Am,2007, 25(3). 625-642.
  • 2Verzola D,Bertolotto MD,Villaggio B,et al.Oxidativestress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells[J]. J Am Soc Nephrol,2004,75(Suppl 1):85-87.
  • 3Levy Ft, M, Molten KP, Prince JM, et al.Systemic inflammation and remote organ injury following trauma require HMCBI[J].Am J Physiol Regul Integr Comp Physiol, 2007,295(4): 15:38-1544.
  • 4Sonnier DI,Makley AT,Friend LA,et aI.Hemorrhagic Shock induces a Proinflammatory Milieu in the Gut Lumen[J].J Surg Res,2011,170(2):272- 279.
  • 5Namas E,Ghuma A,Hermus L,et al.The acute inflammatory response in trauma/hemorr-hage and traumatic brain injury:current stare and emerging prospects[J]. Libyan J Med, 2009,4(5): 97-105.
  • 6洪新,郭振辉,毛宝龄,钱桂生.地塞米松和IL-10对hPBMC促炎细胞因子产生和核转录因子活化的影响[J].中国病理生理杂志,2002,18(11):1328-1332. 被引量:15
  • 7Jansen MJ,Hendriks Th,De Man B,et al. Interleukin-10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice[J]. Cytokine, ; 999, 11 (9): 713-721.
  • 8Ohen DW,Wei Fei Z, Zhang YC,et al.Eole of enteral immunonutrition in patients with gastric carcinoma undergoing major surgery[J].Asian J Surg, 2005,28(2)= 12]-124.
  • 9王进,刘德宏,杨光田.参附注射液对内毒素所致大鼠全身炎症反应综合征的作用[J].中国中西医结合急救杂志,2006,13(1):23-26. 被引量:41
  • 10阮骆阳,林春水.利多卡因对失血性休克兔血浆内皮素和降钙素基因相关肽的影响[J].海南医学,2009,20(9):5-6. 被引量:2

二级参考文献21

  • 1蒋丽.大黄对脓毒症大鼠核因子-κB活化的抑制作用[J].中国中西医结合急救杂志,2004,11(6):364-367. 被引量:29
  • 2刘莹莹,林春水,阮骆阳,古妙宁.利多卡因对失血性休克兔细胞因子的影响[J].实用医学杂志,2007,23(4):461-463. 被引量:2
  • 3J.萨姆布鲁克 E.F弗里奇.分子克隆实验指南(第2版)[M].北京:科学出版社,1996.465-467.
  • 4Christman J W,Lancaster L H,Blackwell T S.Nuclear factor κB:a pivotal role in the systemic inflammatory response syndrome and new target for therapy[J].Intensive Care Med,1998,24:1131-1138.
  • 5Abraham E.Nuclear factor-κB and its role in sepsis-associated organ failure[J].J Infect Dis,2003,187(Suppl 2):S364-S369.
  • 6Takumi T,Yoko K,Hiroko K,et al.Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats[J].Crit Care Med,2004,32:1322-1326.
  • 7Hubert B,Feng Q,Thomas Z,er al.Role of NF-κB in mortality of sepsis[J].Clin Invest,1997,100:972-985.
  • 8Ross L P,Helen F G,Jatinder K D,et al.Increased nuclear factor κB activation in critically ill patients who die[J].Crit Care Med,2002,28:1047-1051.
  • 9Blackwell T S,Christman J W.The role of nuclear κB in cytokine gene regulation[J].Am J Respir Cell Mol Biol,1997,17:3-9.
  • 10Kim P K,Deutschman C S.Inflammatory responses and mediators[J].Surg Clin North America,2000,80:885-894.

共引文献53

同被引文献212

引证文献11

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部